ESC 365 - Evidence for CV event reduction with lower LDL-C.

Open Access

Evidence for CV event reduction with lower LDL-C.

Session: PCSK9 inhibitors: the evidence-based story

Topic: Atherosclerosis

Speaker: Professor C. Packard (Glasgow, GB)

Sponsored by Amgen GmbH

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Professor Chris Packard

Glasgow (United Kingdom of Great Britain & Northern Ireland)

7 presentations

0 follower

5 more presentations in this session

Introduction - PCSK9 inhibitors: the evidence-based story.

Speaker: Professor K. Ray (London, GB)

The LDL-C paradigm.

Speaker: Professor B. Ference (Cambridge, GB)

Atherosclerosis regression and low LDL-C.

Speaker: Professor S. Nicholls (Melbourne, AU)

Panel discussion - PCSK9 inhibitors: the evidence-based story.

Speaker: Professor K. Ray (London, GB)

What questions remain unanswered?

Speaker: Professor K. Ray (London, GB)

Access the full session

PCSK9 inhibitors: the evidence-based story

Speakers: Professor C. Packard, Professor K. Ray, Professor B. Ference, Professor S. Nicholls, Professor K. Ray...

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources